INS and diabetes mellitus: Given all the potentially confounding variables related to the human transplant outcome (eg, immune responses, recipient characteristics, diabetes duration, glycemic control), using cells that result in rapid reversal characterized by large quantitative differences in insulin output seems a logical choice.